Hubbell vs Xylem
Xylem reported revenue of $9.0 billion in fiscal 2025, 1.5 times Hubbell's $5.8 billion in fiscal 2025. Hubbell's revenue grew 3.8% in its latest year, and Xylem's grew 5.5%. Hubbell had an operating margin of 20.7%, against 13.5% at Xylem. Free cash flow was $875 million at Hubbell and $910 million at Xylem.
Side by side
| Hubbell | Xylem | |
|---|---|---|
| Latest fiscal year | FY2025, Dec 31, 2025 | FY2025, Dec 31, 2025 |
| Revenue | $5.8B | $9.0B |
| Revenue growth | 3.8% | 5.5% |
| Revenue growth a year, last 5 years | 9.7% | 13.1% |
| Gross margin | 35.3% | 38.5% |
| Operating margin | 20.7% | 13.5% |
| Net margin | 15.2% | 10.6% |
| Free cash flow | $875M | $910M |
| Free cash flow margin | 15.0% | 10.1% |
| Return on capital | 18.7% | 8.1% |
| Net debt to EBITDA | 1.3x | 0.6x |
| Dividends and buybacks | $225M | $406M |
| Change in diluted share count | −0.9% | 0.2% |
| Last close | $459.40 | $108.24 |
| P/E at the last close | 27.1× | 25.8× |
| Insider trades, last 12 months | bought $186,719, sold $20.4 million | bought $141,098, sold $2.3 million |
| Piotroski F-score | 7 of 9 | 6 of 9 |
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.
Ten years
Revenue
US$ billions, fiscal years
HubbellXylem
Operating margin
Percent of revenue
HubbellXylem
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
HubbellXylem